Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vericel Corp Board/Management Information 2014

May 12, 2014

31799_rns_2014-05-12_dc87c7d7-9891-48f6-87b5-5527f63344bf.zip

Board/Management Information

Open in viewer

Opens in your device viewer

8-K 1 a14-12481_28k.htm 8-K

*UNITED STATES SECURITIES AND EXCHANGE COMMISSION*

*WASHINGTON, D.C. 20549*

*FORM 8-K*

*CURRENT REPORT*

*Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934*

Date of Report (Date of Earliest Event Reported): May 12, 2014 (May 7, 2014)

*Aastrom Biosciences, Inc.*

(Exact name of registrant as specified in its charter)

Michigan 000-22025 94-3096597
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
24 Frank Lloyd Wright Drive, Lobby K, Ann Arbor, Michigan 48105
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (800) 556-0311

*Not Applicable*

Former name or former address, if changed since last report

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

SEQ.=1,FOLIO='',FILE='C:\JMS\C901710\14-12481-2\task6780015\12481-2-ba.htm',USER='C901710',CD='May 12 21:26 2014'

*Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.*

On May 7, 2014, the Board of Directors of Aastrom Biosciences, Inc., a Michigan corporation (the “Company”) appointed Dominick C. Colangelo as the Company’s Chief Accounting Officer and Treasurer. Mr. Colangelo will continue to serve as the Company’s President and Chief Executive Officer, a position he has held with the Company since March 1, 2013.

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\C901710\14-12481-2\task6780015\12481-2-ba.htm',USER='C901710',CD='May 12 21:26 2014'

*SIGNATURES*

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

/s/ DOMINICK C. COLANGELO
Name: Dominick C. Colangelo
Title: Chief Executive Officer and President

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\C901710\14-12481-2\task6780015\12481-2-ba.htm',USER='C901710',CD='May 12 21:26 2014'